Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Immuno-Oncology Technology|October 13, 2025
Protein engineering to overcome limitations of key cytokines in cancer immunotherapy: current approaches and future perspectivesU Salazar, P Cioffi, B Taskoparan, et al.
Immuno-Oncology Technology|August 4, 2025
Properties of CD8 T-cell-recognized neoantigens in different tumor typesS L C Ketelaars, M M van Buuren, A Gangaev, et al.
Immuno-Oncology Technology|July 21, 2025
Thromboembolism in patients with melanoma receiving immune checkpoint inhibitors: incidence and risk factorsD C H van Dorst, M M Hofman, R M de Waal, et al.
Immuno-Oncology Technology|March 19, 2025
Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancerY Pointreau, C Freneaux, T Bejan-Angoulvant, et al.
Immuno-Oncology Technology|August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapyM Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
Immuno-Oncology Technology|July 26, 2024
Regional and intratumoral adoptive T-cell therapyI Olivera, I Etxeberria, C Luri-Rey, et al.
Immuno-Oncology Technology|October 25, 2023
CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer ImmunotherapyJ Dallmann, J Freitag, C Jung, et al.
Immuno-Oncology Technology|February 15, 2024
Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicitiesJ McKenzie, E Sneath, A Trinh, et al.
Immuno-Oncology Technology|September 23, 2024
Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial ProfilerS Böning, F Schneider, A-K Huber, et al.
Immuno-Oncology Technology|March 11, 2026
Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancerA Hahn, S Irenaeus, L C Sandin, et al.
Pageof 10